Pazopanib-Induced Alopecia, an Underestimated Toxicity?

Pazopanib and sunitinib are treatment options for metastatic renal cell cancer (mRCC), with similar efficacy, and minor differences in their toxicity profile. Our experience has suggested that pazopanib-induced alopecia may be a potentially significant but previously under-reported toxicity. For thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Biondo, Andrea, Alexander, Helen, Khabra, Komel, Pickering, Lisa, Gore, Martin, Larkin, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426820/
https://www.ncbi.nlm.nih.gov/pubmed/26029668
http://dx.doi.org/10.3389/fonc.2015.00112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426820/
https://www.ncbi.nlm.nih.gov/pubmed/26029668
http://dx.doi.org/10.3389/fonc.2015.00112

Ejemplares similares